Content about Japan

October 20, 2011

Bristol-Myers Squibb announced changes to its senior management team, including the appointment of its U.S. pharmaceuticals president.

NEW YORK — Bristol-Myers Squibb announced changes to its senior management team, including the appointment of its U.S. pharmaceuticals president.

October 19, 2011

Takeda Pharmaceuticals has started a late-stage clinical trial program for a drug to treat Type 2 diabetes, the drug maker said.

OSAKA, Japan — Takeda Pharmaceuticals has started a late-stage clinical trial program for a drug to treat Type 2 diabetes, the drug maker said.

October 14, 2011

Two classes of drugs for treating Type 2 diabetes will experience the biggest growth in market share of all classes of drugs for the condition, according to a new study by Decision Resources.

BURLINGTON, Mass. — Two classes of drugs for treating Type 2 diabetes will experience the biggest growth in market share of all classes of drugs for the condition, according to a new study by Decision Resources.

The study found that DPP-IV inhibitors and GLP-1 analogues would experience the biggest growth in market share among all drug classes, with a combined market share that will increase from 20% in 2010 to 47% in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

September 30, 2011

Drug maker Takeda has completed its acquisition of another drug maker.

OSAKA, Japan — Drug maker Takeda has completed its acquisition of another drug maker.

Takeda said that the deal, valued at $13 billion, is in line with the company's 2011-2013 mid-range plan, and that Nycomed's significant business infrastructure in Europe and high-growth emerging markets will enhance Takeda's regulatory development expertise and commercialization capability.

September 21, 2011

A study published in the Sept. 20 issue of Neurology, the medical journal of the American Academy of Neurology, found a link between diabetes and the development of dementia.

NEW YORK — A study published in the Sept. 20 issue of Neurology, the medical journal of the American Academy of Neurology, found a link between diabetes and the development of dementia.

August 24, 2011

The final outcome of the battle between Israel’s Teva Pharmaceutical Industries and Canada’s Valeant Pharmaceuticals International to buy Cephalon serves as a good illustration of why it helps to have a plan B.


The final outcome of the battle between Israel’s Teva Pharmaceutical Industries and Canada’s Valeant Pharmaceuticals International to buy Cephalon serves as a good illustration of why it helps to have a plan B.


In May, Teva beat out Valeant’s $5.7 billion offer to buy Frazier, Pa.-based Cephalon with a $6.8 billion offer of its own, acquiring Cephalon’s hefty pipeline in the process. And last month, Teva bought Taiyo Pharmaceutical Industry, Japan’s third-largest generics company, for $934 million.


July 26, 2011

Japanese drug maker Takeda Pharmaceutical is reapplying for approval of two drugs to treat Type 2 diabetes after the Food and Drug Administration turned down its last applications, the company said.

OSAKA, Japan — Japanese drug maker Takeda Pharmaceutical is reapplying for approval of two drugs to treat Type 2 diabetes after the Food and Drug Administration turned down its last applications, the company said.

Takeda announced that it resubmitted its applications for alogliptin and a drug that combines alogliptin with pioglitazone, the active ingredient in Actos, which the FDA approved in 1999.

The FDA will review the applications over the next six months, the drug maker said.

July 14, 2011

OSAKA, Japan — Two diabetes drugs made by Takeda Pharmaceutical Co. have been pulled from the market in France due to evidence that their use may increase the risk of bladder cancer, Takeda said.

Takeda said its French subsidiary, Laboratoires Takeda, would withdraw Actos (pioglitazone) and Competact (pioglitazone and metformin). In addition, Takeda said it was cooperating with the European Medicines Agency in a pan-European of pioglitazone. Competact is marketed in the United States under the brand name Actoplus Met.

June 7, 2011

Procter & Gamble has announced a string of organizational changes, including the appointment of Patrice Louvet as president of global male grooming.

CINCINNATI — Procter & Gamble has announced a string of organizational changes, including the appointment of Patrice Louvet as president of global male grooming.

Louvet, president of global prestige, will serve as president of global male grooming, succeeding Charles "Chip" Bergh, who is retiring from P&G after 28 years of service to pursue his aspiration to be CEO of a major company, the company stated.

May 16, 2011

Generic drug maker Teva Pharmaceutical Industries will acquire a privately owned manufacturer of generic drugs based in Japan, Teva said Monday.

JERUSALEM — Generic drug maker Teva Pharmaceutical Industries will acquire a privately owned manufacturer of generic drugs based in Japan, Teva said Monday.

Teva announced the purchase of a 57% stake in Nagoya, Japan-based Taiyo Pharmaceutical Industry Co. for $460 million, with plans to extend its offer to purchase all remaining shares of the company.

April 20, 2011

Coty recently donated $100,000 to two humanitarian organizations involved in the earthquake relief efforts in Japan, the beauty company announced on Wednesday.

NEW YORK — Coty recently donated $100,000 to two humanitarian organizations involved in the earthquake relief efforts in Japan, the beauty company announced on Wednesday.

April 18, 2011

A U.S. drug maker and its Japanese partner have started a late-stage clinical trial of a drug for treating elevated phosphate levels in the body, the two announced Monday.

NEW YORK — A U.S. drug maker and its Japanese partner have started a late-stage clinical trial of a drug for treating elevated phosphate levels in the body, the two announced Monday.

Keryx Biopharmaceuticals and Torii Pharmaceutical, the pharmaceuticals subsidiary of Japan Tobacco, started a phase-3 trial of Zerenex (ferric citrate) in Japan for patients with hyperphosphatemia. The drug also is in phase-3 trials in the United States as a treatment for hyperphosphatemia in patients with end-stage kidney disease on dialysis.

April 15, 2011

Two Kroger banners have raised funds to benefit Japan earthquake and tsunami victims.

LOS ANGELES — Two Kroger banners have raised funds to benefit Japan earthquake and tsunami victims.

Ralphs and Food 4 Less said they raised more than $100,000 for the American Red Cross' International Response Fund for its Japan relief efforts. The retailers hosted a fundraising campaign that ran from March 21 through April 9.

April 12, 2011

While there’s little chance a tsunami or the gale-force winds of a Hurricane Katrina will ever come crashing through this Cincinnati suburb, John Vota’s Safe & Ready Life store provides home and family safety solutions, along with emergency supplies and services to help prepare homes for both everyday emergencies and natural catastrophes.

MILFORD, Ohio — While there’s little chance a tsunami or the gale-force winds of a Hurricane Katrina will ever come crashing through this Cincinnati suburb, John Vota’s Safe & Ready Life store provides home and family safety solutions, along with emergency supplies and services to help prepare homes for both everyday emergencies and natural catastrophes.

March 30, 2011

A rise in visits to professional outlets for skin care treatments in 2010 gave way to sales growth for the professional skin care products market, with Europe and the United States posting rebounds, according to a recently released study by consulting and research firm Kline.

PARSIPPANY, N.J. — A rise in visits to professional outlets for skin care treatments in 2010 gave way to sales growth for the professional skin care products market, with Europe and the United States posting rebounds, according to a recently released study by consulting and research firm Kline.

March 29, 2011

Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

LONDON — Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

The firm released a report Monday showing that the global biosimilars market, whose value stood at $243 million in 2010, will increase to $3.7 billion by 2015.

March 23, 2011

Safeway's charitable arm announced it would donate $100,000 and launch an employee matching pledge of up to $50,000 to help with the Japan earthquake and tsunami relief efforts.

PLEASANTON, Calif. — Safeway's charitable arm announced it would donate $100,000 and launch an employee matching pledge of up to $50,000 to help with the Japan earthquake and tsunami relief efforts.

The Safeway Foundation said the contribution will be distributed to the impacted area through the American Red Cross.

March 18, 2011

Due to the public concern related to the nuclear incident in Japan, there has been an increased demand for such drugs as potassium iodide (KI), used to prevent and treat the harmful effects of radiation, according to a Food and Drug Administration Web page updated Thursday.

SILVER SPRING, Md. — Due to the public concern related to the nuclear incident in Japan, there has been an increased demand for such drugs as potassium iodide (KI), used to prevent and treat the harmful effects of radiation, according to a Food and Drug Administration Web page updated Thursday.

March 18, 2011

Target has made a donation to Save the Children to assist with Japan’s earthquake and tsunami relief efforts.

MINNEAPOLIS — Target has made a donation to Save the Children to assist with Japan’s earthquake and tsunami relief efforts.

The retailer said it has donated $500,000 to the cause.

Target said it encourages shoppers and team members to visit the Save the Children website to learn more about how they can help victims of the earthquake and tsunami.

March 16, 2011

Kellogg's announced its donation to the American Red Cross to support disaster relief efforts in Japan.

BATTLE CREEK, Mich. — Kellogg's announced its donation to the American Red Cross to support disaster relief efforts in Japan.

The funds, which total $500,000, include equal amounts of cash and product, and are designated to support the efforts of the Japanese Red Cross Society. The cash donation is being made by Kellogg's Corporate Citizenship Fund.

March 16, 2011

Rite Aid’s philanthropic arm is donating to relief efforts in Japan.

CAMP HILL, Pa. — Rite Aid’s philanthropic arm is donating to relief efforts in Japan.

The Rite Aid Foundation announced Wednesday that it was donating $50,000 to the American Red Cross' Japan earthquake fund.

“Our hearts go out to the victims, families and communities affected by this devastating tragedy,” Rite Aid Foundation president Mary Sammons said. “We are proud to partner with the American Red Cross and assist them in their mission of helping the people of Japan in their time of need.”

March 16, 2011

Walmart announced that it is committing $5 million in cash and in-kind donations for emergency relief efforts in response to Japan's recent earthquake and resulting tsunami.

BENTONVILLE, Ark. — Walmart announced that it is committing $5 million in cash and in-kind donations for emergency relief efforts in response to Japan's recent earthquake and resulting tsunami.

Additionally, Walmart operations around the world are planning to implement or already have implemented fundraising drives among associates and customers to provide additional relief funds for the victims.

March 15, 2011

The CVS Caremark Charitable Trust has announced the donation of $100,000 to the American Red Cross in support of relief efforts under way in Japan following last week's tragic earthquake and tsunami, with a potential total donation of up to $300,000 through the matching of CVS Caremark employee donations.

WOONSOCKET, R.I. — The CVS Caremark Charitable Trust has announced the donation of $100,000 to the American Red Cross in support of relief efforts under way in Japan following last week's tragic earthquake and tsunami, with a potential total donation of up to $300,000 through the matching of CVS Caremark employee donations.

March 15, 2011

Drug maker Fleming Pharmaceuticals is increasing production of a drug for preventing thyroid cancer in response to the nuclear crisis in Japan.

ST. LOUIS — Drug maker Fleming Pharmaceuticals is increasing production of a drug for preventing thyroid cancer in response to the nuclear crisis in Japan.

The drug, ThyroShield (potassium iodide), is designed for use in nuclear emergencies and works by saturating the thyroid gland so that it can’t absorb radioactive iodine.

March 9, 2011

Eli Lilly leader John Lechleiter has become something of an evangelist for medical innovation lately. On Wednesday, the Lilly chairman, president and CEO spoke to the U.S./Japan Business Council in Tokyo to call for changes and policies in the biopharmaceutical industry that encourage innovation, or “reinventing invention,” as he called it.

TOKYO — Eli Lilly leader John Lechleiter has become something of an evangelist for medical innovation lately.

On Wednesday, the Lilly chairman, president and CEO spoke to the U.S./Japan Business Council in Tokyo to call for changes and policies in the biopharmaceutical industry that encourage innovation, or “reinventing invention,” as he called it.